184 related articles for article (PubMed ID: 35087823)
1. Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer.
Chen G; Long J; Zhu R; Yang G; Qiu J; Zhao F; Liu Y; Tao J; Zhang T; Zhao Y
Front Cell Dev Biol; 2021; 9():709669. PubMed ID: 35087823
[No Abstract] [Full Text] [Related]
2. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer.
Deng GC; Sun DC; Zhou Q; Lv Y; Yan H; Han QL; Dai GH
BMC Genomics; 2021 Nov; 22(1):791. PubMed ID: 34732125
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
[No Abstract] [Full Text] [Related]
4. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Wang H; Wei C; Pan P; Yuan F; Cheng J
Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
6. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
7. A Prognostic Nomogram Model Based on mRNA Expression of DNA Methylation-Driven Genes for Gastric Cancer.
Chen Z; Liu B; Yi M; Qiu H; Yuan X
Front Oncol; 2020; 10():584733. PubMed ID: 33330065
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer.
Yin X; Kong L; Liu P
Clin Epigenetics; 2021 May; 13(1):109. PubMed ID: 33980289
[TBL] [Abstract][Full Text] [Related]
9. Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer.
Liu B; Zhai J; Wang W; Liu T; Liu C; Zhu X; Wang Q; Tian W; Zhang F
Front Mol Biosci; 2022; 9():872932. PubMed ID: 35517856
[No Abstract] [Full Text] [Related]
10. Development and Validation of a Prognostic Nomogram Based on DNA Methylation-Driven Genes for Patients With Ovarian Cancer.
Zhou M; Hong S; Li B; Liu C; Hu M; Min J; Tang J; Hong L
Front Genet; 2021; 12():675197. PubMed ID: 34567062
[No Abstract] [Full Text] [Related]
11. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically resected pancreatic cancer patients.
Yang J; Tang Y; Wang J; Yu C; Li H; Yi B; Li Y; Zhou J; Zhang Z
Gland Surg; 2022 Oct; 11(10):1697-1711. PubMed ID: 36353587
[TBL] [Abstract][Full Text] [Related]
13. A prognostic 11-DNA methylation signature for lung squamous cell carcinoma.
Zhang J; Luo L; Dong J; Liu M; Zhai D; Huang D; Ling L; Jia X; Luo K; Zheng G
J Thorac Dis; 2020 May; 12(5):2569-2582. PubMed ID: 32642165
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Novel DNA Methylation-Driven Gene Based Molecular Classification and Predictive Model for Overall Survival and Immunotherapy Response in Patients With Glioblastoma: A Multiomic Analysis.
Wang Z; Gao L; Guo X; Lian W; Deng K; Xing B
Front Cell Dev Biol; 2020; 8():576996. PubMed ID: 33015072
[TBL] [Abstract][Full Text] [Related]
15. A Prognostic Model Based on Nine DNA Methylation-Driven Genes Predicts Overall Survival for Colorectal Cancer.
Feng Z; Liu Z; Peng K; Wu W
Front Genet; 2021; 12():779383. PubMed ID: 35126454
[No Abstract] [Full Text] [Related]
16. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
He Z; Deng T; Duan X; Zeng G
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
18. A methylomics-correlated nomogram predicts the recurrence free survival risk of kidney renal clear cell carcinoma.
Zhu X; Ma X; Wu C
Math Biosci Eng; 2021 Oct; 18(6):8559-8576. PubMed ID: 34814313
[TBL] [Abstract][Full Text] [Related]
19. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
[TBL] [Abstract][Full Text] [Related]
20. A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer.
Wei X; Hu W; Mao K
Medicine (Baltimore); 2023 Feb; 102(5):e32766. PubMed ID: 36749233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]